Functional dyspepsia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meeting the diagnostic criteria of FD in accordance with Rome IV classification system; (2) between 18 and 65 years old, regardless of gender; (3) those who did not take FD-related drugs at least 15 days before the first treatment; (4) those who had good compliance and were able to fill in the scale by themselves; (5) signed informed consent and volunteered to participate in this subject, but did not participate in other clinical researchers. Patients who meet the above five criteria at the same time can be included in this study.
Exclusion criteria
Exclusion criteria: (1) symptoms of dyspepsia caused by other chronic diseases; (2) taking or are taking drugs or antibiotics that affect gastrointestinal motility or gastric acid secretion within half a month; (3) patients with severe brain, heart, liver, kidney, lung, hematopoietic system and endocrine system, autoimmune diseases; (4) malignant tumors or other serious consumptive diseases, infectious diseases, hemorrhagic diseases, etc. (5) patients with severe mental and psychological disorders (HAMA = 21 with obvious anxiety), (6) lactating women and women preparing for pregnancy or already pregnant. (7) the expectation of curative effect is too high, and there is no willingness to follow up. Anyone who conforms to any of the above shall be excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal short-chain fatty acids;SP;5-HT;Nipin dyspepsia symptom index;Motilin;Nipin dyspepsia quality of life index;Efficacy evaluation of functional dyspepsia: effective / ineffective;TCM symptom score of functional dyspepsia;Gastric emptying rate;Hamilton anxiety scale; | — |
Countries
China